Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
企業コードINBS
会社名Intelligent Bio Solutions Inc
上場日Dec 23, 2020
最高経営責任者「CEO」Mr. Harry Simeonidis
従業員数13
証券種類Ordinary Share
決算期末Dec 23
本社所在地135 W 41St St,
都市NEW YORK
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号10036
電話番号16467905756
ウェブサイトhttps://ibs.inc/
企業コードINBS
上場日Dec 23, 2020
最高経営責任者「CEO」Mr. Harry Simeonidis
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし